NASDAQ:AKCA - Akcea Therapeutics News Headlines

$22.43
+0.43 (+1.95 %)
(As of 07/23/2019 08:00 AM ET)
Today's Range
$21.59
Now: $22.43
$22.86
50-Day Range
$21.45
MA: $22.97
$25.34
52-Week Range
$19.67
Now: $22.43
$40.75
Volume150,700 shs
Average Volume211,025 shs
Market Capitalization$2.08 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.57

Headlines

Akcea Therapeutics (NASDAQ AKCA) News Headlines

Source:
DateHeadline
Akcea Therapeutics Inc (NASDAQ:AKCA) President Sarah Boyce Sells 1,819 SharesAkcea Therapeutics Inc (NASDAQ:AKCA) President Sarah Boyce Sells 1,819 Shares
www.americanbankingnews.com - July 17 at 5:29 PM
hATTR Compass™ Genetic Testing Program Continues to Expand and Enable Diagnosis and Treatment of Hereditary ATTR Amyloidosis One Year Following LaunchhATTR Compass™ Genetic Testing Program Continues to Expand and Enable Diagnosis and Treatment of Hereditary ATTR Amyloidosis One Year Following Launch
finance.yahoo.com - July 16 at 9:49 AM
Akcea Therapeutics Inc (NASDAQ:AKCA) Given Consensus Recommendation of "Hold" by BrokeragesAkcea Therapeutics Inc (NASDAQ:AKCA) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - July 8 at 4:24 AM
Investors Who Bought Akcea Therapeutics (NASDAQ:AKCA) Shares A Year Ago Are Now Down 13%Investors Who Bought Akcea Therapeutics (NASDAQ:AKCA) Shares A Year Ago Are Now Down 13%
finance.yahoo.com - June 21 at 11:58 AM
Akcea and Ionis Announce Upcoming Data Presentations at the 2019 Peripheral Nerve Society Annual MeetingAkcea and Ionis Announce Upcoming Data Presentations at the 2019 Peripheral Nerve Society Annual Meeting
finance.yahoo.com - June 20 at 6:17 PM
Ionis Pharmaceuticals Is 40% of the Way ThereIonis Pharmaceuticals Is 40% of the Way There
finance.yahoo.com - May 14 at 7:03 PM
Akcea Therapeutics (AKCA) Q1 Earnings and Revenues Lag EstimatesAkcea Therapeutics (AKCA) Q1 Earnings and Revenues Lag Estimates
www.nasdaq.com - May 9 at 9:34 AM
Akcea Therapeutics, Inc. (AKCA) CEO Paula Soteropoulos on Q1 2019 Results - Earnings Call TranscriptAkcea Therapeutics, Inc. (AKCA) CEO Paula Soteropoulos on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 9:34 AM
Akcea Reports Financial Results and Highlights for First Quarter 2019Akcea Reports Financial Results and Highlights for First Quarter 2019
www.globenewswire.com - May 8 at 6:34 PM
Akcea Therapeutics misses on revenueAkcea Therapeutics misses on revenue
seekingalpha.com - May 8 at 6:34 PM
Akcea Q1 revenues up big on license fee from NovartisAkcea Q1 revenues up big on license fee from Novartis
seekingalpha.com - May 8 at 6:34 PM
Can Pfizer Leap Over the Competition With This Potential Blockbuster?Can Pfizer Leap Over the Competition With This Potential Blockbuster?
finance.yahoo.com - May 8 at 9:30 AM
New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN)New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN)
finance.yahoo.com - May 7 at 6:01 PM
Akceas Waylivra conditionally OKd in Europe for rare triglyceride disorderAkcea's Waylivra conditionally OK'd in Europe for rare triglyceride disorder
seekingalpha.com - May 7 at 9:30 AM
Akcea Therapeutics, Inc.: Akcea and Ionis Announce Approval of WAYLIVRA (volanesorsen) in the European UnionAkcea Therapeutics, Inc.: Akcea and Ionis Announce Approval of WAYLIVRA (volanesorsen) in the European Union
www.finanznachrichten.de - May 7 at 9:30 AM
Akceas Waylivra OKd in Europe for rare triglyceride disorderAkcea's Waylivra OK'd in Europe for rare triglyceride disorder
seekingalpha.com - May 7 at 9:30 AM
Akcea and Ionis Announce Approval of WAYLIVRA® (volanesorsen) in the European UnionAkcea and Ionis Announce Approval of WAYLIVRA® (volanesorsen) in the European Union
finance.yahoo.com - May 7 at 9:30 AM
Akcea Therapeutics (AKCA) Earnings Expected to Grow: Should You Buy?Akcea Therapeutics (AKCA) Earnings Expected to Grow: Should You Buy?
finance.yahoo.com - May 1 at 6:19 PM
Here’s What Hedge Funds Think About Akcea Therapeutics, Inc. (AKCA)Here’s What Hedge Funds Think About Akcea Therapeutics, Inc. (AKCA)
finance.yahoo.com - April 26 at 6:01 PM
Akcea Therapeutics (AKCA) Earnings Expected to Grow: What to Know Ahead of Q1 ReleaseAkcea Therapeutics (AKCA) Earnings Expected to Grow: What to Know Ahead of Q1 Release
finance.yahoo.com - April 25 at 6:09 PM
AKCA Makes Bullish Cross Above Critical Moving AverageAKCA Makes Bullish Cross Above Critical Moving Average
www.nasdaq.com - April 2 at 7:44 PM
Akcea Therapeutics (AKCA), Ionis (IONS) Announce Upcoming Data Presentations at ACC.19 - StreetInsider.comAkcea Therapeutics (AKCA), Ionis (IONS) Announce Upcoming Data Presentations at ACC.19 - StreetInsider.com
www.streetinsider.com - March 16 at 10:04 AM
Akcea and Ionis Announce Upcoming Data Presentations at the 2019 American College of Cardiology Meeting (ACC.19)Akcea and Ionis Announce Upcoming Data Presentations at the 2019 American College of Cardiology Meeting (ACC.19)
finance.yahoo.com - March 15 at 6:18 PM
Why Akcea Therapeutics, Inc. (NASDAQ:AKCA) Is A Financially Healthy CompanyWhy Akcea Therapeutics, Inc. (NASDAQ:AKCA) Is A Financially Healthy Company
finance.yahoo.com - March 8 at 6:27 PM
PTC to Expand Product Portfolio in Latin America with WAYLIVRA™ - PRNewswirePTC to Expand Product Portfolio in Latin America with WAYLIVRA™ - PRNewswire
www.prnewswire.com - March 4 at 6:28 PM
Ionis Pharmaceuticals Funds Its Pipeline of More Than 40 DrugsIonis Pharmaceuticals Funds Its Pipeline of More Than 40 Drugs
finance.yahoo.com - March 4 at 6:28 PM
European advisory group backs Akceas Waylivra for rare triglyceride disorderEuropean advisory group backs Akcea's Waylivra for rare triglyceride disorder
seekingalpha.com - March 1 at 9:54 AM
Noteworthy Thursday Option Activity: AKCA, LCI, MARNoteworthy Thursday Option Activity: AKCA, LCI, MAR
www.nasdaq.com - February 28 at 6:05 PM
Akcea® Recognizes Rare Disease Day Through Efforts to Increase Awareness of Hereditary Transthyretin Amyloidosis and Familial Chylomicronemia SyndromeAkcea® Recognizes Rare Disease Day Through Efforts to Increase Awareness of Hereditary Transthyretin Amyloidosis and Familial Chylomicronemia Syndrome
finance.yahoo.com - February 28 at 9:37 AM
Here's Why Ionis Pharmaceuticals Jumped Higher TodayHere's Why Ionis Pharmaceuticals Jumped Higher Today
finance.yahoo.com - February 27 at 6:02 PM
Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2018 - GlobeNewswireAkcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2018 - GlobeNewswire
globenewswire.com - February 26 at 5:43 PM
Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2018Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2018
finance.yahoo.com - February 26 at 5:43 PM
Bullish Two Hundred Day Moving Average Cross - AKCABullish Two Hundred Day Moving Average Cross - AKCA
www.nasdaq.com - February 25 at 6:05 PM
Akcea Therapeutics Inc.Akcea Therapeutics Inc.
www.barrons.com - February 25 at 6:05 PM
Novartis opts in on Akcea lipoprotein candidateNovartis opts in on Akcea lipoprotein candidate
seekingalpha.com - February 25 at 6:05 PM
AKCEA-APO(a)-LRx Advances as Leading Pharmaceutical Company Exercises Option to License - GlobeNewswireAKCEA-APO(a)-LRx Advances as Leading Pharmaceutical Company Exercises Option to License - GlobeNewswire
globenewswire.com - February 25 at 12:02 PM
BRIEF-Akcea Therapeutics Says Co Will Receive A $150 Mln License... - ReutersBRIEF-Akcea Therapeutics Says Co Will Receive A $150 Mln License... - Reuters
www.reuters.com - February 25 at 12:02 PM
AKCEA-APO(a)-LRx Advances as Leading Pharmaceutical Company Exercises Option to LicenseAKCEA-APO(a)-LRx Advances as Leading Pharmaceutical Company Exercises Option to License
finance.yahoo.com - February 25 at 12:02 PM
Akcea Therapeutics to Present at Upcoming Investor Conferences - GlobeNewswireAkcea Therapeutics to Present at Upcoming Investor Conferences - GlobeNewswire
globenewswire.com - February 21 at 5:24 PM
Akcea Therapeutics to Hold Fourth Quarter and Full Year 2018 Financial Results Webcast - GlobeNewswireAkcea Therapeutics to Hold Fourth Quarter and Full Year 2018 Financial Results Webcast - GlobeNewswire
globenewswire.com - February 14 at 5:22 PM
Akcea Therapeutics to Hold Fourth Quarter and Full Year 2018 Financial Results WebcastAkcea Therapeutics to Hold Fourth Quarter and Full Year 2018 Financial Results Webcast
finance.yahoo.com - February 13 at 5:38 PM
AKCA Crosses Below Key Moving Average LevelAKCA Crosses Below Key Moving Average Level
www.nasdaq.com - January 24 at 5:29 PM
Pfizer Gets FDA's Priority Review for Rare Disease CandidatePfizer Gets FDA's Priority Review for Rare Disease Candidate
finance.yahoo.com - January 15 at 9:27 AM
This Biotech Stock Plunged On Its Looming Rivalry With PfizerThis Biotech Stock Plunged On Its Looming Rivalry With Pfizer
finance.yahoo.com - January 14 at 5:13 PM
Top Picks 2019- Ionis Pharmaceuticals IONSTop Picks 2019- Ionis Pharmaceuticals IONS
finance.yahoo.com - January 2 at 4:42 PM
Ionis Announces Plans for Management Transitions in 2020 - PRNewswireIonis Announces Plans for Management Transitions in 2020 - PRNewswire
www.prnewswire.com - December 21 at 9:23 AM
Akcea Announces Upcoming Data Presentations at the 2018 American Society of Hematology Annual MeetingAkcea Announces Upcoming Data Presentations at the 2018 American Society of Hematology Annual Meeting
finance.yahoo.com - November 29 at 9:51 AM
Notable Thursday Option Activity: FDX, BBBY, AKCANotable Thursday Option Activity: FDX, BBBY, AKCA
www.nasdaq.com - November 15 at 4:28 PM
Akcea up 3% on positive AKCEA-APO(a)-Lrx dataAkcea up 3% on positive AKCEA-APO(a)-Lrx data
seekingalpha.com - November 12 at 4:31 PM
Lipoprotein(a) Foundation Hosts Gala Fundraiser to Celebrate Opening of Lipoprotein Exhibition at the International ...Lipoprotein(a) Foundation Hosts Gala Fundraiser to Celebrate Opening of Lipoprotein Exhibition at the International ...
www.businesswire.com - November 9 at 9:35 AM
This page was last updated on 7/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel